Top Hyderabad, Telangana Biotech Companies (28)
Endpoint is an interactive response technology (IRT®) systems and solutions provider that supports the life sciences industry. Since 2009, we have been working with a single vision in mind, to help sponsors and pharmaceutical companies achieve clinical trial success. Our solutions, realized through the proprietary PULSE® platform, have proven to maximize the supply chain, minimize operational costs, and ensure timely and accurate patient dosing. Endpoint is headquartered in Raleigh-Durham, North Carolina with offices across the United States, Europe, and Asia.
Schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. The predictive power of Schrödinger's software allows scientists to accelerate their research and development, reduce research costs, and make novel discoveries.
Analytical scientists and clinical researchers worldwide rely on Agilent to help fulfill their most complex laboratory demands. Our instruments, software, services and consumables address the full range of scientific and laboratory management needs—so our customers can do what they do best: improve the world around us. Whether a laboratory is engaged in environmental testing, academic research, medical diagnostics, pharmaceuticals, petrochemicals or food testing, Agilent provides laboratory solutions to meet their full spectrum of needs. We work closely with customers to help address global trends that impact human health and the environment, and to anticipate future scientific needs. Our solutions improve the efficiency of the entire laboratory, from sample prep to data interpretation and management. Customers trust Agilent for solutions that enable insights...for a better world.
Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and the environment safer, healthier and more sustainable. From the food you eat to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate. Eurofins is a global leader in food, environmental, pharmaceutical and cosmetic product testing and in agroscience CRO services. It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences and in the support of clinical studies. In over just 30 years, Eurofins has grown from one laboratory in Nantes, France to over 61,000 staff across a network of over 1,000 independent companies in 59 countries, operating 940 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Eurofins is one of the fastest growing listed European companies. Since its IPO on the French stock exchange in 1997, Eurofins’ revenues have increased by 33% each year (in compound average) to reach €6.7 billion in 2021.
Clearsynth Labs Limited is a technology oriented and research driven enterprise with the World’s Largest Inventory of High-end research products. Specializes in Stable Isotope Labeled compounds, the synthesis of reference standards, Metabolites, Impurities, Glucuronides, Chiral Compounds and also undertake custom synthesis of complex Molecules or “Difficult to Synthesize” compounds/Intermediates. We have around 200 employees worldwide with it’s Headquarter and Research & Development Centre in Canada & India. Operating at a global level with a network of 5000 + devoted Clientele in 80 Countries, across 5 continents Clearsynth have elevated the scientific community in enriching their discovery in research.
Syngene is an integrated research, development and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene's more than 6,000 scientists offer both skills and the capacity to deliver great science, robust data security, and quality manufacturing, at speed, to improve time-to-market and lower the cost of innovation.
Biological E. Limited (BE), the first private sector biological products company in India and the first pharmaceuticals company in South India was established in 1953. Originally incorporated as Biological Products Private Limited, and launched by Dr. Vijay Kumar Datla, today, BE is a globally recognised vaccine manufacturer and has supplied over 2 Billion Doses of Vaccines till date all over the world. BE supplies several essential and lifesaving Vaccines and Pharmaceuticals to UN Agencies viz. UNICEF, PAHO, many global markets, and in India to the National Immunization Program, various State Governments, PSUs, Indian Armed Forces and the domestic retail market. With a mission to improve health and survival of people and contribute to the societies BE serves by providing equitable access to quality vaccines and therapeutics. BE has a long and richly textured history of supporting public health programs in India for over five decades. Our portfolio of WHO pre-qualified vaccines include the 5-in-1 Pentavalent and a Japanese Encephalitis vaccine and our future offerings promise to be even more exciting.
Sai Life Sciences is built on the bedrock of partnership. We work with innovator pharma and biotech companies to accelerate the discovery, development and manufacture of complex small molecules for a healthier tomorrow. Our Vision is to support our global innovator partners bring 25 new medicines to life by 2025. And we are well on that journey.
CLONZ is a biopharmaceutical firm promoted by a group of young and passionate Biotechnologists, focused on the development, manufacturing and commercialization of Human Therapeutic biosimilar Monoclonal Antibodies (MAbs). Clonz got incorporated in 2009 and started its operations in September 2010 at Genome Valley, Hyderabad, India With experienced team coming from recognized leaders in recombinant biosimilar manufacturing, Clonz is committed to delivering quality biologics to make treatment and care affordable to the world population in many disease indications, with special emphasis on Oncology.
Sanzyme is the first generation biotech healthcare company, established in 1969 as the first Indo-Japanese JV with Sankyo, Japan. Then it was called as Uni-Sankyo. Sanzyme is a specialist in Healthcare specialities covering Infertility gonadotropins, probiology, sexology, nephrology, urology and nutraceuticals. Sanzyme's fermentation wing is into aqua, poultry, veterinary probiotics in addition to recent bioremediation initiative. Sanzyme has three manufacturing facilities, R&D, marketing and distribution, exports and bioanalytics. Sanzyme also makes products on contract manufacturing basis.
Bridging gap between Scientific community and enterprise farming.
Agriculture and DCM Shriram Limited are often spoken of in the same breath. When DCM Shriram Limited took over the management of Bioseed in 2002, the move was seen as yet another initiative by DCM Shriram Limited to create value in the farmlands of India and beyond. Huge investments in people, research labs and seed processing infrastructure followed the takeover. Today, Bioseed owns a vast pool of germplasm, among the richest in the world. The gene pool has sprouted one of the highest success rates in all of Asia. When expansion plans took root, Bioseed strengthened its operations in Vietnam and The Philippines and extended its coverage to Indonesia, Thailand, Bangladesh, Laos, Cambodia, Nepal and China. The company's pan-Asian spread allows cross-fertilization of ideas. The yield: Unique biotechnology-based solutions for the benefit of countries with similar climatic and soil conditions. The mission: Empowering farmers with high-yielding solutions of the future, from the right hybrids to better cultivation techniques.
Viatris is a global pharmaceutical company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer.
Indian Immunologicals Ltd (IIL) is the market leader in veterinary and human biologicals in India. It manufactures over 150+ products. IIL operates one of the largest plants in the world for veterinary vaccines. IIL has adequate infrastructure and cold chain distribution capability to reach out to various parts of India and world market. This flexibility in logistics has ensured many products of IIL occupy top slots in the market. IIL is a major player in the human vaccine market in India, focusing on the pediatric and rabies vaccine segments. IIL is also a major supplier of pediatric vaccines to India’s large Universal Immunization Programme.
Quanticate is a leading global data focused clinical research organisation (CRO) primarily focused on the management, analysis and reporting of data from clinical trials and post-marketing surveillance. As experts in clinical data, Quanticate provides high quality teams that offer efficient outsourcing solutions for: • Clinical Data Management • Biostatistics • SAS Programming • Data quality oversight via Centralized Statistical Monitoring • Medical writing • Pharmacovigilance Quanticate can offer study level support, functional service provision (FSP), strategic full data-services solutions or technical consultancy to meet the needs of pharmaceutical, biotechnology and device companies across the globe. Quanticate has become the supplier of choice for many companies from top tier pharmaceutical giants through to niche biotechnology and device companies.
Mapmygenome™ uses genomics to personalize health and well-being. Our at-home DNA tests and diagnostic genomic tests provide DNA-based insights that enable consumers, physicians, and health service providers to create a personalized health journey. Established in 2013, Mapmygenome™ has a vision to “Touch 100 million lives and save a million lives by 2030. Some of the preventive genomic tests that Mapmygenome™ offers are Genomepatri, BeautyMap, MyFitGene, Cardiomap, MedicaMap, and MapmyBiome. MapMyGenome also helps people discover their ethnic roots with Genomepatri Heritage.
Aryastha Life Science shines as a beacon of innovation and leadership, illuminating the pharmaceutical and biotechnology sectors. We fearlessly address and deliver the intricate challenges within drug discovery and development with unwavering determination. Our foundation is built upon years of transformative experience, culminating in Aryastha's inception. Aryastha represents the culmination of dedicated efforts to overcome scientific barriers spanning various facets of drug discovery and development. Our overarching mission is to provide innovative and integrated solutions that de-risk and streamline drug discovery and development, driving toward a healthier future. We are committed to add value by understanding the unique needs of our clients, collaborating with global Biotech and Pharmaceutical partners, and leveraging our capabilities to fuel advancements in healthcare.
Established in 2012, Tierra Seed Science Private Limited is a next generation agriculture technology company focused on developing innovative seeds stacked with proprietary traits (Non Genetically Modified) that apart from providing significant yield and cost advantage to farmers, has very high impact on environment. Founded by professionals with more than seven decades of combined seed and agribusiness industry experience. Tierra is headquartered in Hyderabad, the seed capital of India, with additional research and breeding facilities in Pune and Vijayawada. Tierra is guided by its vision to address important challenges faced by farmers, food/agri processors and consumers ensuring a "Million Smiles” Tierra is focussed on development of traits and superior products in four focus crops - Cotton, Rice, Tomato and Corn. Tierra uses several advanced technology tools to develop its products. We use marker assisted selection, mutation breeding, TILLING, among other advanced genomics tools to develop new traits and better products. Tierra R&D unit has been recognized by Department of Scientific and Industrial Research (DSIR) under Ministry of Science and Technology, Govt. of India. We are a B2B license based company. We develop traits, stack them into seeds, license seeds and traits to independent seed companies who in turn market them to the farmers. We empower small seed companies in Asia and Africa to provide new products and compete in the market. Our focus is on creating Intellectual Property (IP) and Plant Variety Protected (PVP) products. Our business model follows strict compliance with all regulatory guidelines including Freedom To Operate (FTO) guidelines. We collaborate with research institutes and seed companies for technology development partnerships. We have active collaboration on research and technology partnerships with over 15 national and international institutes. Tierra has adequate infrastructure that includes 40 acres of research farms in Hyde
Welcome to LifeCell, where innovation thrives and caring for your health is at the heart of everything we do. We believe in the power of science and technology to transform lives, and we're on a mission to make advanced healthcare accessible and affordable to all. At LifeCell, we understand that your health is not just a number on a chart, but a vital aspect of your well-being and happiness. That's why we're here to assist you at every stage of life, ensuring you and your loved ones receive the care and support you deserve. We strive to revolutionize every category we venture into, empowering individuals and families with cutting-edge technologies. For instance, we're proud to have achieved a remarkable >97% success rate in finding stem cell transplant matches for Indians, giving hope to those in need. Our rapid genomics testing delivers timely interventions for better health outcomes, especially in pregnant women and infants, ensuring that no precious moment is missed.
BioGenex designs, develops, and commercializes advanced fully-automated molecular pathology systems for cancer diagnosis, prognosis, personalized medicine, and life science research. The recent introduction of our eFISHency integrated workflow solution for FISH laboratories and miRNA system for characterization of cancer of unknown primary (CUP) and for undifferentiated tumors is a game changer that has no rival in the industry. Our fully automated molecular pathology work stations are the most advanced system globally. Our customer focused approach, with premier after sales support and excellent technical service, provides the best in class customer care. Our spirit of innovation drives us to deliver cutting edge technology, years ahead of our competition, and the finest systems for life science research and diagnostics.
Work Your Passion. Live Your Purpose.
